Deferred Tax Assets, Operating Loss Carryforwards of CytoDyn Inc. from 31 May 2012 to 31 May 2025

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
CytoDyn Inc. quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD history and change rate from 31 May 2012 to 31 May 2025.
  • CytoDyn Inc. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending 31 May 2025 was $97,626,000, a 3.2% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Change (%)

CytoDyn Inc. Quarterly Deferred Tax Assets, Operating Loss Carryforwards (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $97,626,000 -$3,271,000 -3.2% 31 May 2025 10-K 25 Jul 2025 2025 FY
Q2 2024 $100,897,000 +$4,559,000 +4.7% 31 May 2024 10-K 25 Jul 2025 2025 FY
Q2 2023 $96,338,000 -$10,627,000 -9.9% 31 May 2023 10-K 15 Aug 2024 2024 FY
Q2 2022 $106,965,000 +$32,707,000 +44% 31 May 2022 10-K 14 Sep 2023 2023 FY
Q2 2021 $74,258,000 +$18,634,000 +34% 31 May 2021 10-K 15 Aug 2022 2022 FY
Q2 2020 $55,624,000 +$15,627,439 +39% 31 May 2020 10-K 30 Jul 2021 2021 FY
Q2 2019 $39,996,561 +$10,766,282 +37% 31 May 2019 10-K 14 Aug 2020 2020 FY
Q2 2018 $29,230,279 -$3,300,157 -10% 31 May 2018 10-K 14 Aug 2019 2019 FY
Q2 2017 $32,530,436 +$9,019,828 +38% 31 May 2017 10-K 27 Jul 2018 2018 FY
Q2 2016 $23,510,608 +$6,653,008 +39% 31 May 2016 10-K 20 Jul 2017 2017 FY
Q2 2015 $16,857,600 +$6,900,200 +69% 31 May 2015 10-K 19 Jul 2016 2016 FY
Q2 2014 $9,957,400 +$1,701,400 +21% 31 May 2014 10-K 10 Jul 2015 2015 FY
Q2 2013 $8,256,000 +$1,939,000 +31% 31 May 2013 10-K 10 Jul 2014 2014 FY
Q2 2012 $6,317,000 31 May 2012 10-K 29 Aug 2013 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.